Caseware UK (AP4) 2023.0.135 2023.0.135 2023-11-302022-12-01falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 07446850 2022-12-01 2023-11-30 07446850 2021-12-01 2022-11-30 07446850 2023-11-30 07446850 2022-11-30 07446850 c:Director1 2022-12-01 2023-11-30 07446850 c:RegisteredOffice 2022-12-01 2023-11-30 07446850 d:MotorVehicles 2022-12-01 2023-11-30 07446850 d:MotorVehicles 2023-11-30 07446850 d:MotorVehicles 2022-11-30 07446850 d:MotorVehicles d:OwnedOrFreeholdAssets 2022-12-01 2023-11-30 07446850 d:ComputerEquipment 2022-12-01 2023-11-30 07446850 d:ComputerEquipment 2023-11-30 07446850 d:ComputerEquipment 2022-11-30 07446850 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-12-01 2023-11-30 07446850 d:OwnedOrFreeholdAssets 2022-12-01 2023-11-30 07446850 d:CurrentFinancialInstruments 2023-11-30 07446850 d:CurrentFinancialInstruments 2022-11-30 07446850 d:CurrentFinancialInstruments d:WithinOneYear 2023-11-30 07446850 d:CurrentFinancialInstruments d:WithinOneYear 2022-11-30 07446850 d:ShareCapital 2023-11-30 07446850 d:ShareCapital 2022-11-30 07446850 d:RetainedEarningsAccumulatedLosses 2023-11-30 07446850 d:RetainedEarningsAccumulatedLosses 2022-11-30 07446850 c:OrdinaryShareClass1 2022-12-01 2023-11-30 07446850 c:OrdinaryShareClass1 2023-11-30 07446850 c:OrdinaryShareClass1 2022-11-30 07446850 c:FRS102 2022-12-01 2023-11-30 07446850 c:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 07446850 c:FullAccounts 2022-12-01 2023-11-30 07446850 c:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 07446850 6 2022-12-01 2023-11-30 07446850 d:AcceleratedTaxDepreciationDeferredTax 2023-11-30 07446850 d:AcceleratedTaxDepreciationDeferredTax 2022-11-30 07446850 d:OtherDeferredTax 2023-11-30 07446850 d:OtherDeferredTax 2022-11-30 07446850 1 2023-11-30 07446850 3 2023-11-30 07446850 1 2022-11-30 07446850 3 2022-11-30 07446850 f:PoundSterling 2022-12-01 2023-11-30 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 07446850










DR MANISH RAVAL LTD
UNAUDITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023





















 
DR MANISH RAVAL LTD
 
 
Company Information


Director
Dr M Raval 




Registered number
07446850



Registered office
3rd Floor
12 Gough Square

London

EC4A 3DW





 
DR MANISH RAVAL LTD
Registered number: 07446850

Balance sheet
As at 30 November 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
21,801
32,582

Investments
 5 
1,126,425
950,055

  
1,148,226
982,637

Current assets
  

Debtors: amounts falling due within one year
 6 
45,084
43,194

Cash at bank and in hand
  
327,393
308,776

  
372,477
351,970

Creditors: amounts falling due within one year
 7 
(94,123)
(56,869)

Net current assets
  
 
 
278,354
 
 
295,101

Total assets less current liabilities
  
1,426,580
1,277,738

Provisions for liabilities
  

Deferred tax
 8 
(11,726)
(18,992)

  
 
 
(11,726)
 
 
(18,992)

Net assets
  
1,414,854
1,258,746


Capital and reserves
  

Called up share capital 
 9 
200
200

Profit and loss account
  
1,414,654
1,258,546

  
1,414,854
1,258,746


Page 1

 
DR MANISH RAVAL LTD
Registered number: 07446850
    
Balance sheet (continued)
As at 30 November 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 August 2024.


Dr M Raval
Director

The notes on pages 7 to 13 form part of these financial statements.

Page 2

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

1.


General information

Dr Manish Raval Ltd is a private company limited by shares incorporated in the United Kingdom and registered in England and Wales. The company's registered office is 3rd Floor, 12 Gough Square, London, EC4A 3DW.
The principal activity for the company during the year was the provision of consultant anaesthetic services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The following principal accounting policies have been applied:

  
2.2

Turnover

Turnover comprises revenue receivable by the company in respect of services supplied during the year. Commissions payable in respect of referrals given are shown separately within administration expenses.

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Motor vehicles
-
20%
Computer equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 3

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

2.Accounting policies (continued)

 
2.4

Valuation of investments

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

             
 
Page 4

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

2.Accounting policies (continued)


2.7
Financial instruments (continued)

                   Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

               Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 5

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

2.Accounting policies (continued)

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2).

Page 6

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

4.


Tangible fixed assets





Motor vehicles
Computer equipment
Total

£
£
£



Cost or valuation


At 1 December 2022
59,240
-
59,240


Additions
-
1,372
1,372



At 30 November 2023

59,240
1,372
60,612



Depreciation


At 1 December 2022
26,658
-
26,658


Charge for the year on owned assets
11,848
305
12,153



At 30 November 2023

38,506
305
38,811



Net book value



At 30 November 2023
20,734
1,067
21,801



At 30 November 2022
32,582
-
32,582

Page 7

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

5.


Fixed asset investments





Listed investments
Other fixed asset investments
Total

£
£
£



Cost or valuation


At 1 December 2022
941,351
8,704
950,055


Additions
357,218
594
357,812


Disposals
(178,589)
(8,500)
(187,089)


Revaluations
5,647
-
5,647



At 30 November 2023
1,125,627
798
1,126,425






Net book value



At 30 November 2023
1,125,627
798
1,126,425



At 30 November 2022
941,351
8,704
950,055

Page 8

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

6.


Debtors

2023
2022
£
£


Trade debtors
37,847
35,979

Prepayments and accrued income
7,237
6,752

Tax recoverable
-
463

45,084
43,194



7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
1,007
9,010

Corporation tax
80,803
39,156

Other creditors
2,353
2,703

Accruals and deferred income
9,960
6,000

94,123
56,869



8.


Deferred taxation




2023


£






At beginning of year
(18,992)


Charged to profit or loss
7,266



At end of year
(11,726)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(5,450)
(11,108)

Gain on investment in listed shares
(6,276)
(7,884)

(11,726)
(18,992)

Page 9

 
DR MANISH RAVAL LTD
 
 
 
Notes to the financial statements
For the year ended 30 November 2023

9.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



200 (2022 - 200) Ordinary Shares shares of £1.00 each
200
200



10.


Pension commitments

The company operates a pension scheme on behalf of its employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
The pension cost charge represents contributions payable by the company to the fund and amounted to £15,000 (2022: £15,000).
Contributions totalling £Nil (2022: £Nil) were payable to the fund at the balance sheet date.

 
Page 10